Tectonic Therapeutic, Inc. (TECX)
Healthcare
Biotechnology
—
27.90 $
-0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Tectonic Therapeutic, Inc. (TECX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -18 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.3 | -8.5 | -12 | -9.3 | -13 | -20 | -17 | -13 | -15 | -18 | -14 | -18 | -65 | |
| 0.2 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.5 | 0.4 | 0.7 | 0.3 | 0.7 | 0.3 | 2.0 | |
| – | 0.3 | 0.3 | 0.3 | 0.4 | 1.7 | 1.1 | 2.1 | 4.7 | 2.8 | 5.1 | 3.2 | 16 | |
| 1.4 | 0.6 | -3.8 | 2.9 | -3.3 | -4.3 | -5.6 | -0.2 | 1.8 | -2.6 | 0.9 | 2.8 | 2.9 | |
| 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.3 | |
| -0.2 | 0.0 | -0.1 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.1 | -0.2 | 0.0 | 0.0 | -0.1 | |
| – | – | – | – | – | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.5 | |
| -0.3 | -0.1 | 34 | -0.7 | 180 | -6.3 | -1.1 | 178 | -4.2 | -0.5 | -0.1 | 0.8 | -3.9 | |
| 53 | -19 | -77 | 62 | 166 | -26 | -18 | 165 | -19 | -18 | -15 | -17 | -69 | |
| -0.5 | -8.5 | -12 | -9.3 | -13 | -20 | -17 | -13 | -15 | -18 | -14 | -18 | -66 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.